Loading...

StemRIM

4599.T•JPX
Healthcare
Biotechnology
¥329.00
¥7.00(2.17%)

StemRIM (4599.T) Financial Performance & Income Statement Overview

Review StemRIM (4599.T) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.

Revenue Growth
-100.00%
↓ 100.00%
Operating Income Growth
-1557.96%
↓ 1557.96%
Net Income Growth
-1301.07%
↓ 1301.07%
Operating Cash Flow Growth
-265.72%
↓ 265.72%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-23.72%
↓ 23.72%
ROIC
-25.48%
↓ 25.48%

StemRIM (4599.T) Income Statement & Financial Overview

View the income breakdown for StemRIM 4599.T across both annual and quarterly reports.

MetricQ2 2025Q1 2025Q4 2024Q3 2024
Revenue$0.00$0.00$0.00$0.00
Cost of Revenue$11.34M$0.00$11.15M$11.09M
Gross Profit-$11.34M$0.00-$11.15M-$11.09M
Gross Profit Ratio
R&D Expenses$360.46M$379.11M$351.81M$369.90M
SG&A Expenses$121.05M$194.11M$172.13M$137.44M
Operating Expenses$481.52M$573.22M$523.95M$507.34M
Total Costs & Expenses$492.86M$573.22M$523.95M$518.43M
Interest Income$0.00$4000.00$0.00$0.00
Interest Expense$0.00$0.00$0.00$0.00
Depreciation & Amortization$11.34M$11.30M$11.15M$11.09M
EBITDA-$476.09M-$561.92M-$513.00M-$501.39M
EBITDA Ratio
Operating Income-$492.86M-$573.22M-$523.95M-$518.43M
Operating Income Ratio
Other Income/Expenses (Net)$5.43M$13.72M$21.40M$5.95M
Income Before Tax-$487.43M-$559.50M-$502.55M-$512.48M
Income Before Tax Ratio
Income Tax Expense$907000.00$908000.00$619000.00$907000.00
Net Income-$488.34M-$560.40M-$503.17M-$513.39M
Net Income Ratio
EPS-$7.86-$9.11-$8.18-$8.35
Diluted EPS-$7.86-$9.11-$8.18-$8.35
Weighted Avg Shares Outstanding$62.14M$61.53M$61.52M$61.48M
Weighted Avg Shares Outstanding (Diluted)$62.14M$61.53M$61.52M$61.48M

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;